[go: up one dir, main page]

GB0022748D0 - Reducing the content of cells in a biological sample - Google Patents

Reducing the content of cells in a biological sample

Info

Publication number
GB0022748D0
GB0022748D0 GBGB0022748.8A GB0022748A GB0022748D0 GB 0022748 D0 GB0022748 D0 GB 0022748D0 GB 0022748 A GB0022748 A GB 0022748A GB 0022748 D0 GB0022748 D0 GB 0022748D0
Authority
GB
United Kingdom
Prior art keywords
cells
reducing
content
biological sample
biological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0022748.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allied Therapeutics Ltd
Original Assignee
Allied Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allied Therapeutics Ltd filed Critical Allied Therapeutics Ltd
Priority to GBGB0022748.8A priority Critical patent/GB0022748D0/en
Publication of GB0022748D0 publication Critical patent/GB0022748D0/en
Priority to AU2001286116A priority patent/AU2001286116A1/en
Priority to PCT/GB2001/004126 priority patent/WO2002024307A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3493—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate using treatment agents in suspension
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0043—Catheters; Hollow probes characterised by structural features
    • A61M2025/0056—Catheters; Hollow probes characterised by structural features provided with an antibacterial agent, e.g. by coating, residing in the polymer matrix or releasing an agent out of a reservoir

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0022748.8A 2000-09-15 2000-09-15 Reducing the content of cells in a biological sample Ceased GB0022748D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0022748.8A GB0022748D0 (en) 2000-09-15 2000-09-15 Reducing the content of cells in a biological sample
AU2001286116A AU2001286116A1 (en) 2000-09-15 2001-09-14 Reducing the content of particular cell types in a biological sample
PCT/GB2001/004126 WO2002024307A2 (en) 2000-09-15 2001-09-14 Reducing the content of particular cell types in a biological sample

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0022748.8A GB0022748D0 (en) 2000-09-15 2000-09-15 Reducing the content of cells in a biological sample

Publications (1)

Publication Number Publication Date
GB0022748D0 true GB0022748D0 (en) 2000-11-01

Family

ID=9899579

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0022748.8A Ceased GB0022748D0 (en) 2000-09-15 2000-09-15 Reducing the content of cells in a biological sample

Country Status (3)

Country Link
AU (1) AU2001286116A1 (en)
GB (1) GB0022748D0 (en)
WO (1) WO2002024307A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080254551A1 (en) * 2004-12-30 2008-10-16 Achsel Tilmann Immunoprecipitaion-Based Method to Purify and Characterise Biological Macromolecular Complexes
LT2021025T (en) 2006-05-12 2017-01-25 Ith Immune Therapy Holdings Ab Method and means for treating inflammatory bowel disease
DE102008045127A1 (en) * 2008-09-01 2010-03-04 Heinrich, Hans-Werner, Prof. Dr. Filter system for extracorporeal depletion of activated polymorphonuclear granulocytes (polymorphonuclear leukocytes PMNs)
CN102186880A (en) 2008-09-10 2011-09-14 Ith免疫治疗控股股份公司 Treating inflammatory conditions
EP2485783A4 (en) * 2009-10-07 2014-01-01 Univ Pittsburgh DEVICES, SYSTEMS AND METHODS FOR MODIFICATION OF CELLS
GB2479536A (en) * 2010-04-12 2011-10-19 Jon Lacy-Colson Blood filtration device for removing tumour cells

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9965A (en) 1853-08-23 Jonathan foreman
JPS61134325A (en) 1984-12-04 1986-06-21 Teijin Ltd Expression of hybrid antibody gene
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
DE69119683T2 (en) 1990-07-27 1996-10-02 Pall Corp Leukocyte removal filter and method of use
US5460945A (en) * 1991-05-30 1995-10-24 Center For Blood Research, Inc. Device and method for analysis of blood components and identifying inhibitors and promoters of the inflammatory response
WO1993006850A1 (en) * 1991-10-03 1993-04-15 The Center For Blood Research Plasmodium falciparum-infected erythrocytes binding to icam-1 and cd36
ATE199392T1 (en) 1992-12-04 2001-03-15 Medical Res Council MULTIVALENT AND MULTI-SPECIFIC BINDING PROTEINS, THEIR PRODUCTION AND USE
WO1997002851A1 (en) 1995-07-10 1997-01-30 Asahi Medical Co., Ltd. System and treating extracorporeally circulating blood for curing inflammatory diseases

Also Published As

Publication number Publication date
WO2002024307A2 (en) 2002-03-28
WO2002024307A3 (en) 2003-10-16
AU2001286116A1 (en) 2002-04-02

Similar Documents

Publication Publication Date Title
GB0031716D0 (en) Sensor cell
GB0020964D0 (en) Improvements in or relating to containers
EP1299168A4 (en) Mini-cyclone biocollector and concentrator
EP1333086A4 (en) Cell culture case
EP1194774A4 (en) Water sampling with analyte extraction and integration
GB0000356D0 (en) Improvements in or relating to containers
GB2358061B (en) Improvements in and relating to the collection and storage of samples
GB0004016D0 (en) Biological material and uses thereof
AU2001229770A1 (en) Improved research and development process
AUPQ520600A0 (en) Improvements in electrolysis cells
GB0117235D0 (en) Improvements in or relating to electrochemical cells
GB0006429D0 (en) Electrochemical cell
GB0022748D0 (en) Reducing the content of cells in a biological sample
GB0029625D0 (en) Electrochemical cells and their packaging
GB0006428D0 (en) Electrochemical cell
AU2001270478A1 (en) Gene expression in biological conditions
GB2380614B (en) Electrochemical cells
GB0012184D0 (en) Suface analysis
GB2372810B (en) Support and method for cell based assays
GB9904038D0 (en) Improvements in or related to microfluidic sample preparation and mass spectrometry
GB0022017D0 (en) Cell assays
AU2001254976A1 (en) Electrochemical methods and cells
EP1051915A4 (en) Fermented organic acid that changes cell and protein functions
GB0130675D0 (en) Improvements in and relating to analysis
AU2001256680A1 (en) Hiv-producing cell line and use thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)